BBBT — Black Bird Biotech Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $0.73m
- $0.08m
Annual income statement for Black Bird Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0.058 | 0.104 | 0.083 |
| Cost of Revenue | |||||
| Gross Profit | — | — | 0.029 | 0.02 | 0.03 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 0.084 | 0.08 | 0.742 | 1.56 | 1.37 |
| Operating Profit | -0.084 | -0.08 | -0.685 | -1.45 | -1.29 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -0.121 | -0.122 | -0.69 | -1.81 | -1.66 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -0.121 | -0.122 | -0.69 | -1.81 | -1.66 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -0.121 | -0.122 | -0.69 | -1.81 | -1.66 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -0.121 | -0.122 | -0.69 | -1.81 | -1.66 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.001 | -0.001 | -0.006 | -0.009 | -0.005 |